Proof-of-Concept Study Evaluating Total Body Weight, Physical Function & Safety of Enobosarm in Patients Treated With GLP-1 Receptor Agonist, for Weight Loss

Clinical trial NCT07446998 · RECRUITING

Trial details

NCT number: NCT07446998
Sponsor: Veru Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Obesity & Overweight Mobility Disability HOMA-IR

Start date: 2026-03-26
Primary completion: 2027-10-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.